Monday December 21, 2020 0 comments
DENVER -- BioIntelliSense, Inc. announced it has been named Best of Innovation as a CES 2021 Innovation Awards honoree for the BioButton medical-grade wearable device and data services.
The "Best of Innovation" award is given to only the highest-rated product in each category and is not assured for any category in any year unless the total scores for a product exceed an exceptional threshold.
The innovation award announcement was made ahead of the first all-digital CES 2021, the world's most influential technology event, happening Jan. 11-14, 2021.
The BioButton is a coin-sized, disposable medical wearable device for continuous monitoring of temperature, heart rate and respiratory rate at rest to enable early detection of adverse vital sign trends through its proprietary biosensor technology and advanced analytics.
"We are extremely honored to be named Best of Innovation as a CES 2021 Innovation Award honoree,” said James Mault, BioIntelliSense CEO.
“The commercial launch of the BioButton COVID-19 symptom screening and vaccine monitoring solution is timely in addressing the growing challenge of safe return to worksites, school, travel, conferences and entertainment.
"The BioButton is the newest addition to our biosensor portfolio and data services model for public health and clinical applications that span infectious disease, orthopedics, oncology, and cardiac care."
The CES Innovation Awards program, owned and produced by the Consumer Technology Association, is an annual competition honoring outstanding design and engineering in consumer technology products across 28 product categories.
An elite panel of industry expert judges, including members of the media, designers, engineers and more, reviewed submissions based on innovation, engineering and functionality, aesthetic and design.
The CES 2021 Innovation Awards Honorees, including product descriptions and photos, can be found at CES.tech/innovation.